These authors studied the possibility of implementing a diagnostic algorithm using CA19-9, OPN, and TIMP1 and found a diagnostic accuracy of 89.5% in differentiating patients with pancreatic adenocarcinoma, patients with chronic pancreatitis, and healthy people. This evidence concerns the gene TIMP1 and pancreatic adenocarcinoma.